143 related articles for article (PubMed ID: 35878719)
1. Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain.
Mikkelsen JD; Aripaka SS; Bascuñana P; Bankstahl M; Bankstahl JP; Pazarlar BA
Neuroscience; 2022 Sep; 499():142-151. PubMed ID: 35878719
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model.
Contreras-García IJ; Pichardo-Macías LA; Santana-Gómez CE; Sánchez-Huerta K; Ramírez-Hernández R; Gómez-González B; Rocha L; Mendoza Torreblanca JG
Epilepsy Behav; 2018 Nov; 88():283-294. PubMed ID: 30336420
[TBL] [Abstract][Full Text] [Related]
3. Temporal and spatial changes in synaptic vesicle glycoprotein 2A (SV2A) under kainic acid induced epileptogenesis: An autoradiographic study.
Pazarlar BA; Madsen CA; Oyar EÖ; Eğilmez CB; Mikkelsen JD
Epilepsy Res; 2022 Jul; 183():106926. PubMed ID: 35526328
[TBL] [Abstract][Full Text] [Related]
4. Neuronal degeneration is observed in multiple regions outside the hippocampus after lithium pilocarpine-induced status epilepticus in the immature rat.
Scholl EA; Dudek FE; Ekstrand JJ
Neuroscience; 2013 Nov; 252():45-59. PubMed ID: 23896573
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
Thomsen MB; Jacobsen J; Lillethorup TP; Schacht AC; Simonsen M; Romero-Ramos M; Brooks DJ; Landau AM
J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280
[TBL] [Abstract][Full Text] [Related]
7. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
Gillard M; Chatelain P; Fuks B
Eur J Pharmacol; 2006 Apr; 536(1-2):102-8. PubMed ID: 16556440
[TBL] [Abstract][Full Text] [Related]
8. Commonalities and differences in extracellular levels of hippocampal acetylcholine and amino acid neurotransmitters during status epilepticus and subsequent epileptogenesis in two rat models of temporal lobe epilepsy.
Meller S; Brandt C; Theilmann W; Klein J; Löscher W
Brain Res; 2019 Jun; 1712():109-123. PubMed ID: 30703372
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.
Ohno Y; Tokudome K
CNS Neurol Disord Drug Targets; 2017; 16(4):463-471. PubMed ID: 28393712
[TBL] [Abstract][Full Text] [Related]
10. A single dose of cocaine raises SV2A density in hippocampus of adolescent rats.
Rossi R; Bærentzen SL; Thomsen MB; Real CC; Wegener G; Grassi-Oliveira R; Gjedde A; Landau AM
Acta Neuropsychiatr; 2024 Apr; 36(2):109-117. PubMed ID: 36847240
[TBL] [Abstract][Full Text] [Related]
11. Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE.
Zhao W; Li Y; Sun H; Zhang W; Li J; Jiang T; Jiang L; Meng H
J Cell Mol Med; 2023 Dec; 27(24):4045-4055. PubMed ID: 37845841
[TBL] [Abstract][Full Text] [Related]
12. Exploring with [
Serrano ME; Bahri MA; Becker G; Seret A; Germonpré C; Lemaire C; Giacomelli F; Mievis F; Luxen A; Salmon E; Rogister B; Raedt R; Plenevaux A
Mol Imaging Biol; 2020 Oct; 22(5):1197-1207. PubMed ID: 32206990
[TBL] [Abstract][Full Text] [Related]
13. Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure.
Hanaya R; Hosoyama H; Sugata S; Tokudome M; Hirano H; Tokimura H; Kurisu K; Serikawa T; Sasa M; Arita K
Neuroscience; 2012 Sep; 221():12-20. PubMed ID: 22766234
[TBL] [Abstract][Full Text] [Related]
14. Binding of the monoacylglycerol lipase (MAGL) radiotracer [
Mikkelsen JD; Aripaka SS; Egilmez CB; Pazarlar BA
Neurochem Int; 2024 May; 175():105717. PubMed ID: 38447759
[TBL] [Abstract][Full Text] [Related]
15. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model.
André V; Dubé C; François J; Leroy C; Rigoulot MA; Roch C; Namer IJ; Nehlig A
Epilepsia; 2007; 48 Suppl 5():41-7. PubMed ID: 17910580
[TBL] [Abstract][Full Text] [Related]
17. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.
Bertoglio D; Verhaeghe J; Wyffels L; Miranda A; Stroobants S; Mrzljak L; Dominguez C; Skinbjerg M; Bard J; Liu L; Munoz-Sanjuan I; Staelens S
J Nucl Med; 2022 Jun; 63(6):942-947. PubMed ID: 34531262
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the Properties of the Rat Hippocampus Glutamatergic System in the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy.
Diespirov GP; Postnikova TY; Griflyuk AV; Kovalenko AA; Zaitsev AV
Biochemistry (Mosc); 2023 Mar; 88(3):353-363. PubMed ID: 37076282
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE).
Pazarlar BA; Aripaka SS; Petukhov V; Pinborg L; Khodosevich K; Mikkelsen JD
Mol Brain; 2022 May; 15(1):45. PubMed ID: 35578248
[TBL] [Abstract][Full Text] [Related]
20. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
